ADDISON, Texas, Sept. 21 /PRNewswire-FirstCall/ -- The Regents of the University of California, under its United States Department of Energy (DOE) contract to manage and operate Lawrence Livermore National Laboratory (LLNL) and CDT Systems, Inc. (OTC Bulletin Board: CDTN), have executed an additional license under patent rights whereby CDT Systems will have rights to manufacture and market Carbon Aerogel worldwide, except for capacitor fields of use. This second LLNL license specifically authorizes CDT Systems to manufacture Carbon Aerogel for use as an electrode for the generation of hydrogen from water by hydrolysis and the development of proprietary variable pore-size Carbon Aerogel electrodes. CDT Systems currently has a patent license agreement with LLNL for Capacitive Deionization Technology for brackish water/sea water desalination and treatment of heat exchanger and boiler water, industrial and commercial process water and ultrapure industrial water. CDT Systems' manufacturing facility is scheduled to initially produce 80,000 square feet of proprietary Carbon Aerogel electrodes per month. Current Carbon Aerogel applications include brackish water desalination, industrial and coalbed methane groundwater water remediation, hydrogen generation and Carbon Aerogel for CDT Systems' alliance partners' technologies. The Company is the nonexclusive business, technology licensee, and manufacturing associate of the U.S. Department of Energy's Lawrence Livermore National Laboratory ("LLNL") for the development and commercialization of Carbon Aerogel material sciences-based capacitive deionization technology (CDT) for water purification, as well as Carbon Aerogel for hydrogen generation, insulation, including fuel cells and nanotechnology electrodes. Statements about CDT's outlook and all other statements in this release other than historical facts are forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. These forward-looking statements rely upon a number of assumptions concerning future events and are subject to a number of uncertainties and other factors outside CDT's control, which could cause actual results to differ materially from such statements. While CDT believes that the assumptions concerning future events are reasonable, it cautions that there are inherent difficulties in predicting certain important factors that could impact the future performance. Among the important factors that could cause actual results to differ materially are the completion of the manufacturing facility and the demand for CDT's products. These and other risk factors are discussed in CDT's filings with the Securities and Exchange Commission, copies of which are available to the public. CDT expressly disclaims any intention or obligation to revise or update any forward-looking statements whether as a result of new information, future events, or otherwise. Contact Information: Mr. Dallas Talley, CEO, Capacitive Deionization Technology Systems, Inc. (CDT Systems), Addison, Texas, phone (972) 934-1586; e-mail: email@example.com
SOURCE CDT Systems, Inc.